Date | Analyst | Company | Last | Target | Call | Valuation |
01/10/22 | Citi Research | Ifast Corp | 7.85 | 7.5 | Sell | |
01/10/22 | DBS Vickers | Ifast Corp | 7.85 | 11.37 | Buy | DCF |
01/10/22 | UBS | Ifast Corp | 7.85 | 11 | Buy | |
01/13/22 | UOB Kay Hian | Ifast Corp | 7.86 | 9.75 | Buy | DCF |
01/27/22 | Citi Research | Ifast Corp | 6.84 | 6.2 | Sell | |
02/15/22 | Citi Research | Ifast Corp | 6.18 | 5.2 | Sell | |
02/15/22 | DBS Vickers | Ifast Corp | 6.18 | 10.85 | Buy | DCF |
02/15/22 | CIMB | Ifast Corp | 6.18 | 7.6 | Add | |
02/17/22 | UOB Kay Hian | Ifast Corp | 6.36 | 9.84 | Buy | DCF |
04/25/22 | Citi Research | Ifast Corp | 5.66 | 5.2 | Sell | |
04/25/22 | DBS Vickers | Ifast Corp | 5.66 | 8.75 | Buy | DCF |
04/25/22 | UOB Kay Hian | Ifast Corp | 5.66 | 5.17 | Hold | PER40.3x FY22, Buy @ $4.40 |
04/26/22 | Citi Research | Ifast Corp | 5.31 | 4.2 | Sell | |
04/26/22 | DBS Vickers | Ifast Corp | 5.31 | 5.42 | Hold | DCF |
07/20/22 | Citi Research | Ifast Corp | 4.12 | 3.8 | Sell | |
07/25/22 | Lim & Tan | Ifast Corp | 3.99 | 5.93 | Neutral | |
07/26/22 | DBS Vickers | Ifast Corp | 3.87 | 4.08 | Hold | DCF |
07/26/22 | CIMB | Ifast Corp | 3.87 | 4 | Hold | |
10/27/22 | DBS Vickers | Ifast Corp | 3.82 | 4 | Hold | |
10/28/22 | UOB Kay Hian | Ifast Corp | 3.96 | 3.62 | Hold | PER30x FY23 |
10/28/22 | Citi Research | Ifast Corp | 3.96 | 3.8 | Sell | |
10/28/22 | CIMB | Ifast Corp | 3.96 | 3.8 | Hold | |
12/13/22 | Citi Research | Ifast Corp | 5.92 | 3.8 | Sell | |
01/16/23 | DBS Vickers | Ifast Corp | 5.86 | 3.98 | Fully Valued | DCF |
02/15/23 | Lim & Tan | Ifast Corp | 5.43 | 3.8 | Avoid | |
02/16/23 | UOB Kay Hian | Ifast Corp | 5.53 | 5.06 | Hold | PER42x FY23 |
02/16/23 | CIMB | Ifast Corp | 5.53 | 3.5 | Reduce | |
02/16/23 | Citi Research | Ifast Corp | 5.53 | 3.8 | Sell |
Saturday, April 15, 2023
Ifast Corp - Stock calls
Hyphens Pharma - Stock calls
Date | Analyst | Company | Last | Target | Call | Valuation |
01/07/22 | CIMB | Hyphens Pharma | 0.295 | 0.36 | Add | DCF, PER13.5x FY22 |
04/04/22 | Amfrasers | Hyphens Pharma | 0.29 | 0.38 | Outperform | PER15x FY22 |
04/07/22 | SAC Capital | Hyphens Pharma | 0.3 | 0.4 | Buy | |
05/13/22 | Lim & Tan | Hyphens Pharma | 0.28 | 0.37 | Buy | |
05/20/22 | CIMB | Hyphens Pharma | 0.28 | 0.36 | Add | |
05/20/22 | SAC Capital | Hyphens Pharma | 0.28 | 0.4 | Buy | |
06/06/22 | Phillip | Hyphens Pharma | 0.295 | 0.43 | Buy | DCF |
08/18/22 | CIMB | Hyphens Pharma | 0.315 | 0.39 | Add | DCF |
08/29/22 | Phillip | Hyphens Pharma | 0.31 | 0.43 | Buy | DCF |
11/25/22 | CIMB | Hyphens Pharma | 0.3 | 0.4 | Add | DCF |
03/09/23 | Phillip | Hyphens Pharma | 0.35 | 0.445 | Buy | DCF |
04/13/23 | CIMB | Hyphens Pharma | 0.34 | 0.4 | Add | DCF |
Hwa Hong - Stock calls
Date | Analyst | Company | Last | Target | Call | Valuation |
05/17/22 | Lim & Tan | Hwa Hong | 0.29 | 0.37 | Accept Offer | Offer price $0.37 |
06/08/22 | Lim & Tan | Hwa Hong | 0.4 | 0.4 | Accept Offer | Offer price $0.4 |
06/20/22 | UOB Kay Hian | Hwa Hong | 0.395 | 0.4 | Accept Offer | Offer price $0.4 |
Stock calls for 14 April 2023
Date | Analyst | Company | Last | Target | Call | Valuation |
04/14/23 | UOB Kay Hian | Comfortdelgro | 1.2 | 1.29 | Hold | |
04/14/23 | DBS Vickers | Comfortdelgro | 1.2 | 1.66 | Buy | |
04/14/23 | Lim & Tan | GuocoLand | 1.63 | 2.3 | Overweight | |
04/14/23 | Lim & Tan | Innotek | 0.495 | 0.6 | Accumulate | |
04/14/23 | DMG & Partners | SGX | 9.54 | 9 | Neutral | PER20x |